Hematology

Hematology has two closely linked sides. Benign, or non-cancerous, hematology deals with disorders such as anemia, low or abnormal blood counts, and problems with how the blood clots, many of which are common and treatable once the cause is found. Hematologic oncology deals with cancers of the blood and lymphatic system, including the leukemias, lymphomas and myeloma, which are serious diseases that nonetheless respond increasingly well to modern treatment. The same specialist often follows a patient across both worlds, because an abnormal blood count can point to either a simple deficiency or a serious disease, and only the right tests can tell them apart. This is why a careful, staged diagnosis is the heart of the field.

The conditions are wide-ranging. Anemias, including iron, vitamin B12 and folate deficiency anemias, are among the most common reasons for referral, alongside low white cells or platelets. Blood cancers include the acute and chronic leukemias, Hodgkin and non-Hodgkin lymphoma, multiple myeloma, and the myelodysplastic and myeloproliferative diseases. Bleeding and clotting disorders include hemophilia and other inherited and acquired conditions that cause abnormal bleeding or an abnormal tendency to form clots. Inherited disorders of the red cells, such as thalassemia and sickle cell disease, are also managed here, often from childhood. Therapeutic apheresis, which filters and treats the blood, and bone marrow transplantation are dedicated areas that support the treatment of the most serious diseases.

Treatment is matched precisely to the diagnosis. Many non-cancerous conditions are corrected with medication, iron or vitamin replacement, or by treating an underlying cause, and transfusion supports patients whose blood counts are low. For blood cancers, chemotherapy delivered in a high-standard service remains a mainstay, increasingly combined with targeted and immune-based therapies that act on the specific disease. Therapeutic apheresis removes or exchanges components of the blood for selected conditions. For some patients, a bone marrow transplant replaces diseased marrow with healthy blood-forming cells and offers the prospect of a cure. These treatments are supported by strong laboratory, transfusion and intensive care services, and the more intensive ones are delivered as inpatient care with careful protection against infection.

Diagnosis in hematology rests on examining the blood itself. The complete blood count measures the red cells, white cells and platelets, and a blood film examines their appearance under the microscope, often giving the first clue to the diagnosis. Clotting tests assess how well the blood forms a clot, and a reticulocyte count shows how actively new red cells are being made. When a clearer picture is needed, a bone marrow examination samples the factory where blood is produced, and genetic and immunology tests identify the precise type of a leukemia or lymphoma, which now guides modern targeted treatment. Imaging stages lymphoma and assesses lymph nodes and organs, so that the whole disease is mapped before treatment begins.

For people travelling from abroad, the journey depends on the diagnosis. Reaching the diagnosis is usually outpatient and can often be completed within a few days, with blood tests, a bone marrow examination if needed and the results discussed before a plan is set. Treatment then varies widely. Some patients need only medication or day-unit infusions and can largely manage from accommodation nearby, while intensive chemotherapy or a bone marrow transplant means a longer stay, sometimes several weeks of inpatient care with strict protection against infection. Because blood disease often needs continuing follow-up, the plan is designed so that monitoring and supportive care can continue with a doctor at home once the intensive phase is complete. Interpreter and international patient support guide the whole pathway.